Lymphoma, Non-Hodgkin Clinical Trials

333 clinical trials for Lymphoma, Non-Hodgkin across international registries, including 32 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008) — RECRUITING · PHASE1
• eHealth Mindfulness-based Music Therapy Intervention for Patients Undergoing Stem Cell Transplantation — RECRUITING · NA
• Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols — RECRUITING
• Tissue Collection for Studies of Lymph Cancer — RECRUITING
• A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring — RECRUITING · PHASE1
• CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies — RECRUITING · PHASE1
• TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas — RECRUITING · PHASE1
• Evaluation of Lymphoma Prognosis and Survivorship in Recently Diagnosed Patients, LEO Study — RECRUITING
• A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 ) — RECRUITING · PHASE1
• A Study of JNJ-95566692 in Participants With Non-Hodgkin Lymphoid Malignancies — RECRUITING · PHASE1
• Toxin Exposure and Immune Dysregulation in Non-Hodgkin Lymphoma — RECRUITING
• Faecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation — RECRUITING · PHASE2
• Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases — RECRUITING · PHASE2
• Clinical Trial Assessing the Immunogenicity of an Anti-pneumococcal Vaccination Strategy (PCV13+PPV23 Versus PREVENAR20) in Adult Patients Treated for a Lymphoma — RECRUITING · PHASE4
• TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer — RECRUITING · PHASE2
• A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies — RECRUITING · PHASE1
• Epcoritamab-CAR T Cells for Large B-cell Lymphomas — RECRUITING · PHASE2
• AI-based Predictive and Interventional System for Early Detection of Non-compliance Risks With Oral Therapies in Lymphoma Patients. — RECRUITING
• Interrupting Sedentary Time to Improve Cardiometabolic Health and Toxicity in Patients With Lymphoma Receiving Chemotherapy: The iSTAND Trial — RECRUITING · NA
• Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR) — RECRUITING · PHASE2
• Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy — RECRUITING · PHASE2
• Long-Term Follow-up Study — RECRUITING
• A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas. — RECRUITING · PHASE1
• Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease — RECRUITING
• Family Study of Lymphoproliferative Disorders — RECRUITING
• Evaluation of the Role of Connected Scales in the Therapeutic Care of Hematology Patients — RECRUITING · NA
• T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL) — RECRUITING · PHASE1
• A Phase I/II Trial of ALETA-001 for the Treatment of Participants With B-cell Malignancies — RECRUITING · PHASE1
• Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study III — RECRUITING
• A Novel CAR-T Combined Expression of IL-15 in the Treatment of Malignant Hematological Tumors — RECRUITING · NA
• CD19-directed CAR-T Cell Therapy for R/R Acute Leukemia and Lymphoma — RECRUITING · PHASE1
• Cellular Immunotherapy for Relapsed or Refractory Lymphoma Data Collection — RECRUITING
• Electronic Health Mindfulness-based Music Therapy Intervention for Patients Undergoing Allogeneic Stem Cell Transplantation — COMPLETED · NA
• Genome Expression in Lymphoma, Leukemia and Multiple Myeloma — COMPLETED
• A Study of JNJ-80948543, a T-cell Redirecting CD79b x CD20 x CD3 Trispecific Antibody, in Participants With Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL) — ACTIVE_NOT_RECRUITING · PHASE1
• A Study of JNJ-80948543 in Combination With Other CD3 T-Cell Engagers in Participants With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (R/R B-Cell NHL) — ACTIVE_NOT_RECRUITING · PHASE1
• A Study of JNJ-87801493 in Combination With T-Cell Engagers in Participants With B-cell Non-Hodgkin Lymphoid (NHLs) Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• A Study of JNJ-90014496 in Participants With B-Cell Non-Hodgkin Lymphoma — ACTIVE_NOT_RECRUITING · PHASE1
• A Study of JNJ-88998377 for Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma — ACTIVE_NOT_RECRUITING · PHASE1
• A Phase 1/2 Study of UB-VV400 With Rapamycin in Relapsed/Refractory B-cell Malignancies — NOT_YET_RECRUITING · PHASE1
• Study to Evaluate the Safety and Efficacy of a Combination of Favezelimab (MK-4280) and Pembrolizumab (MK-3475) in Participants With Hematologic Malignancies (MK-4280-003) — TERMINATED · PHASE1
• Study to Evaluate the Role of Siltuximab in Treatment of Cytokine Release Syndrome (CRS) and Immune Effector Cell Associated Neurotoxicity (ICANS) Related to CAR-T Cell Therapy — COMPLETED · PHASE2
• Primary Bone Mature B-Cell NHL in Children — COMPLETED
• Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression — COMPLETED · PHASE3
• Study of Oral LOXO-338 in Patients With Advanced Blood Cancers — COMPLETED · PHASE1
• Study of CD30 CAR for Relapsed/Refractory CD30+ HL and CD30+ NHL — ACTIVE_NOT_RECRUITING · PHASE1
• A Safety Study of PF-08046045/SGN-35T in Adults With Advanced Cancers — TERMINATED · PHASE1
• DZD8586 in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma — COMPLETED · PHASE1
• A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adults With Hodgkin and Non-Hodgkin Lymphoma — TERMINATED · PHASE1
• A Study to Evaluate Safety and Clinical Activity of GSK5926371 in Adult Participants With Relapsed or Refractory B-NHL — NOT_YET_RECRUITING · PHASE1

Refine this search